The clearest difference was in ALP
Two fracture treatments were associated with higher serum mineral markers than the fracture-control group in a rat experiment, but the pattern was not the same across all markers. Compared with fracture controls, free zingiberene was associated with higher calcium, phosphate, magnesium and alkaline phosphatase activity, known as ALP. The zingiberene-selenium nanoparticle formulation was associated with higher calcium, phosphate and ALP, but not magnesium. In the direct comparison, ALP activity was higher with the formulation than with free zingiberene.
The fracture-control group had lower serum calcium, phosphate, magnesium and ALP than intact, non-fractured controls. Calcium and phosphate were each reported at p < 0.0001 for the fracture-control versus intact comparison. For the formulation versus fracture control, the reported p values were 0.0015 for calcium, 0.0001 for phosphate and 0.306 for magnesium. The direct ALP comparison between treatments was reported at p = 0.0002.
A four-group rat experiment
The researchers evaluated free zingiberene and a zingiberene-selenium nanoparticle formulation in a rat femoral-fracture model. The study focused on mineral, oxidative, inflammatory, bone-turnover, molecular, radiographic and histological responses.
Twenty-four adult male Wistar rats, aged five months and reported to weigh 150 ± 10 g, were randomly allocated to four groups of six: intact control, fracture control, fracture plus free zingiberene, and fracture plus the formulation. Treatment was given by daily oral gavage from day 1 after fracture for 35 days. The free-zingiberene dose was 10 mg/kg/day, while the formulation dose was 0.5 mg/kg/day expressed as total administered formulation mass.
The fracture model was unfixed and did not include standardized grading of alignment, rotation or shortening. Analgesia and daily monitoring were provided, no animals were excluded, and all 24 animals completed the experimental period.
Continuous endpoints were analyzed with one-way ANOVA, a test used to compare several group averages, with Benjamini-Hochberg false-discovery-rate and Bonferroni correction. Pairwise comparisons used Tukey testing after an omnibus effect remained significant after false-discovery-rate correction. Biochemical endpoints had six values per group, while qPCR endpoints had three.
What the formulation contained
The formulation was prepared from 0.1 M aqueous sodium selenite and zingiberene. A 1% v/v solution of ascorbic acid was added dropwise, followed by 24 hours of stirring at room temperature. The resulting red-orange color was considered consistent with elemental selenium formation.
Available dynamic-light-scattering characterization indicated an approximately 400 to 500 nm hydrodynamic size, a polydispersity index of 0.383 and an approximately positive 10 to 20 mV zeta potential. These measurements did not establish the formulation's morphology, loading, release, stability, uptake, circulation or improved bioavailability.
The comparison also involved different administered amounts: 10 mg/kg/day of free zingiberene versus 0.5 mg/kg/day of the total formulation mass. It was therefore a comparison of two treatment regimens rather than equal administered doses.
A narrow result from a small study
The group size of six was selected from comparable published animal studies rather than from a formal a priori power calculation. The qPCR analyses were based on three values per group, leaving fewer measurements for those molecular comparisons than for the biochemical endpoints.
The central finding is selective rather than uniform. Both treatments were associated with higher calcium, phosphate and ALP than fracture control, but only free zingiberene was associated with higher magnesium, and the formulation's significant between-treatment difference was in ALP. Calcium, phosphate and magnesium did not differ significantly between the two treatment groups.
Taken together, the results describe a treatment-associated pattern under this specific rat fracture model and dosing schedule. Because the formulation and free compound were given at different administered amounts, the mineral results alone cannot identify why the formulation had higher ALP. The work remains animal evidence, not a direct treatment result in people.
Paper data and sources
Original title: A zingiberene–selenium nanoparticle formulation modulates oxidative, inflammatory, and osteogenic responses during femoral fracture healing in rats
Authors: Albarakati A
Journal/Repository: Frontiers in veterinary science
Status: Peer-reviewed
First online: 2026-10-19
DOI: Not available
Original paper · Full text